Cancers, Vol. 16, Pages 1755: Activation of the Anaphase Promoting Complex Restores Impaired Mitotic Progression and Chemosensitivity in Multiple Drug-Resistant Human Breast Cancer
Cancers, Vol. 16, Pages 1755: Activation of the Anaphase Promoting Complex Restores Impaired Mitotic Progression and Chemosensitivity in Multiple Drug-Resistant Human Breast Cancer
Cancers doi: 10.3390/cancers16091755
Authors:
Mathew Lubachowski
Cordell VanGenderen
Sarah Valentine
Zach Belak
Gerald Floyd Davies
Terra Gayle Arnason
Troy Anthony Alan Harkness
The development of multiple-drug-resistant (MDR) cancer all too often signals the need for alternative toxic therapy or palliative care. Our recent in vivo and in vitro studies using canine MDR lymphoma cancer cells demonstrate that the Anaphase Promoting Complex (APC) is impaired in MDR cells compared to normal canine control and drug-sensitive cancer cells. Here, we sought to establish whether this phenomena is a generalizable mechanism independent of species, malignancy type, or chemotherapy regime. To test the association of blunted APC activity with MDR cancer behavior, we used matched parental and MDR MCF7 human breast cancer cells, and a patient-derived xenograft (PDX) model of human triple-negative breast cancer. We show that APC activating mechanisms, such as APC subunit 1 (APC1) phosphorylation and CDC27/CDC20 protein associations, are reduced in MCF7 MDR cells when compared to chemo-sensitive matched cell lines. Consistent with impaired APC function in MDR cells, APC substrate proteins failed to be effectively degraded. Similar to our previous observations in canine MDR lymphoma cells, chemic...
Source: Cancers - Category: Cancer & Oncology Authors: Mathew Lubachowski Cordell VanGenderen Sarah Valentine Zach Belak Gerald Floyd Davies Terra Gayle Arnason Troy Anthony Alan Harkness Tags: Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemistry | Chemotherapy | Lymphoma | Palliative | Palliative Care | Study | Toxicology